Spots Global Cancer Trial Database for nervous system diseases
Every month we try and update this database with for nervous system diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Research on the Application and Mechanism of New Biological Probes in Biomedicine | NCT04977739 | Tumors Cardiovascular ... Respiratory Sys... Digestive Syste... Endocrine Syste... Metabolic Disea... Immune System D... Urinary System ... Nervous System ... Blood Diseases Infectious Dise... | No intervention | 18 Years - 70 Years | Nanfang Hospital, Southern Medical University | |
| Exploring Outcomes and Characteristics of Myasthenia Gravis 2 | NCT06002945 | Myasthenia Grav... | Blood sample | 18 Years - | Yale University | |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma | NCT01290692 | Grade IV Glioma Grade IV Astroc... Glioblastoma Mu... | TVI-Brain-1 | 18 Years - | TVAX Biomedical | |
| Research on the Application and Mechanism of New Biological Probes in Biomedicine | NCT04977739 | Tumors Cardiovascular ... Respiratory Sys... Digestive Syste... Endocrine Syste... Metabolic Disea... Immune System D... Urinary System ... Nervous System ... Blood Diseases Infectious Dise... | No intervention | 18 Years - 70 Years | Nanfang Hospital, Southern Medical University | |
| The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis | NCT05917184 | Myasthenia Grav... | Telehealth | 18 Years - | Yale University | |
| Research on the Application and Mechanism of New Biological Probes in Biomedicine | NCT04977739 | Tumors Cardiovascular ... Respiratory Sys... Digestive Syste... Endocrine Syste... Metabolic Disea... Immune System D... Urinary System ... Nervous System ... Blood Diseases Infectious Dise... | No intervention | 18 Years - 70 Years | Nanfang Hospital, Southern Medical University | |
| A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China | NCT05638269 | Essential Hyper... Liver Cancer Nasopharyngeal ... Pancreatic Canc... Lung Cancer Chronic Kidney ... Acute Coronary ... Epilepsy Gastric Cancer Primary Aldoste... Subclinical hyp... | no intervention | 18 Years - 75 Years | Zhujiang Hospital | |
| The Impact of Myasthenia Gravis in the Real World | NCT04176211 | Myasthenia Grav... | 18 Years - | Vitaccess Ltd | ||
| Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends | NCT04865679 | Symptomatic Neu... Amputation Chronic Nerve P... | Axoguard Nerve ... | 18 Years - 80 Years | Axogen Corporation | |
| DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors | NCT02197169 | Glioblastoma or... | Single intratum... Interferon-gamm... | 18 Years - | DNAtrix, Inc. | |
| Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation | NCT05321498 | Mild Cognitive ... Alzheimer Disea... Dementia Brain Diseases Central Nervous... Nervous System ... Tauopathies Neurodegenerati... Mental Disorder... | XPro1595 Placebo | 55 Years - 80 Years | Inmune Bio, Inc. | |
| The Impact of Myasthenia Gravis in the Real World | NCT04176211 | Myasthenia Grav... | 18 Years - | Vitaccess Ltd | ||
| A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China | NCT05638269 | Essential Hyper... Liver Cancer Nasopharyngeal ... Pancreatic Canc... Lung Cancer Chronic Kidney ... Acute Coronary ... Epilepsy Gastric Cancer Primary Aldoste... Subclinical hyp... | no intervention | 18 Years - 75 Years | Zhujiang Hospital | |
| Predictors and Prognostic Factors of Myasthenia Gravis Outcome | NCT05214612 | Myasthenia Grav... Autoimmune Dise... Neuromuscular J... Thymoma Thymus Hyperpla... Nervous System ... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... | Drug treatment ... | 16 Years - | Assiut University | |
| Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation | NCT05321498 | Mild Cognitive ... Alzheimer Disea... Dementia Brain Diseases Central Nervous... Nervous System ... Tauopathies Neurodegenerati... Mental Disorder... | XPro1595 Placebo | 55 Years - 80 Years | Inmune Bio, Inc. | |
| Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends | NCT04865679 | Symptomatic Neu... Amputation Chronic Nerve P... | Axoguard Nerve ... | 18 Years - 80 Years | Axogen Corporation | |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma | NCT01290692 | Grade IV Glioma Grade IV Astroc... Glioblastoma Mu... | TVI-Brain-1 | 18 Years - | TVAX Biomedical | |
| Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma | NCT01081223 | Glioma High Grade Astr... Glioblastoma Mu... | Cancer vaccine ... | 18 Years - | TVAX Biomedical |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
